Keefe Bruyette lowered the firm’s price target on Bill (BILL) to $46 from $54 and keeps a Market Perform rating on the shares post the fiscal Q4 report. The firm cut estimates citing the company’s weaker than expected outlook. The outlook reflects continued macro uncertainty and it is tough to be optimistic Bill “given the uncertainty that has persisted for quite some time,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BILL:
